NCT05692752 is a clinical trial of No intervention in Myocardial Infarction, Acute, sponsored by Islamia University of Bahawalpur.

Who is sponsoring NCT05692752?

NCT05692752 is sponsored by Islamia University of Bahawalpur.

What drugs are being tested in NCT05692752?

Interventions in NCT05692752: No intervention.

What condition does NCT05692752 study?

NCT05692752 studies Myocardial Infarction, Acute.

Is NCT05692752 still recruiting?

NCT05692752 is currently completed. Last updated 20 January 2023.

Last reviewed 2023-01-20 · How we verify

NCT05692752

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Expression of microRNA-133a and microRNA-208b in Acute Myocardial Infarction

Completed Last updated 20 January 2023

What this trial tests

trial testing No intervention in Myocardial Infarction, Acute in 10 participants. Completed in 14 January 2023.

Timeline

28 December 2022

Primary endpoint
10 January 2023

14 January 2023

Quick facts

Lead sponsor	Islamia University of Bahawalpur
Status	Completed
Study type	OBSERVATIONAL
Enrollment	10
Start date	28 December 2022
Primary completion	10 January 2023
Estimated completion	14 January 2023
Sites	1 location across Egypt

Drugs / interventions tested

No intervention

Conditions studied

Myocardial Infarction, Acute — all drugs for Myocardial Infarction, Acute →

Sponsor

Islamia University of Bahawalpur

Who can join

Adults 35 to 65, any sex, with Myocardial Infarction, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiac-enriched micro-RNAs (miRNAs), micro RNA 208b and 133a(MiR-208b, MiR-133a)) corresponds to the health and disorders of the cardiovascular system. An intron of the cardiac myosin heavy chain gene MYH7 encodes miR-208b. It is found on chromosome 14 in humans. Identify new diagnostic biomarkers based on miRNAs, researchers examine the expression of miR-133a and 208b at various time points (04 hours, 08 hours, 12 hours, 24 hours, 48 hours) following the development of the infarct and compared it to the traditional myocardial infarction biomarkers cardiac troponine (cTnl) and Creatine kinase-MB (CK-MB).

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Oxidative Stress and MicroRNAs in Endothelial Cells under Metabolic Disorders.
Minjares M, Wu W, Wang JM. · · 2023 · cited 30× · PMID 37174741 · DOI 10.3390/cells12091341
Extracellular Vesicles as Diagnostic Metrics for Cardiovascular Disease: Where We are and How to Achieve in Clinics.
Wang Y, Yuan Y, Tang J. · · 2025 · cited 1× · PMID 40457135 · DOI 10.1007/s12265-025-10629-8
Expression of microRNA-133a and microRNA-208b in acute myocardial infarction; A randomized clinical trial
Ibrahim S, Osama D, Hegazy A, Hashmi H, et al · · 2023 · DOI 10.21203/rs.3.rs-2995851/v1

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Myocardial Infarction, Acute

Currently open trials in the same condition.

NCT07181317 — WAMIF: Prospective Study in Young Women Presenting Acute Myocardial Infarction: Cohort Follow up · recruiting
NCT07008391 — High-Sensitivity Troponin I in Addition to Guideline-Based Care in EMS · NA · recruiting
NCT05759078 — Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Defici · Phase 4 · recruiting
NCT05198791 — Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries. · Phase 2 · recruiting
NCT04968808 — Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI) · NA · recruiting

Other Islamia University of Bahawalpur trials

Trials by the same sponsor.

NCT07042555 — Efficacy of Cognitive Behavior Therapy for Treatment of Chronic Pelvic Pain in Women · NA · not yet recruiting
NCT06445790 — Efficacy of Cognitive Behavior Therapy in the Treatment of Chronic Pelvic Pain in Women · NA · not yet recruiting
NCT06562764 — To Evaluate Newly Developed Pictogram Cards and Their Utility in Improving Inhaler Techniques in Asthmatic Patients · NA · active not recruiting
NCT06123078 — Impact of Schemas, Cognitive Emotion Regulation on Quality of Life of HIV Patients: Assessing Outcomes of CBT · NA · completed
NCT05254977 — Post Vaccination Adverse Events in Covid-19 Vaccine Recipients · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05692752 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Islamia University of Bahawalpur
Last refreshed: 20 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05692752.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing